Prognostic clinical and biological markers for amyotrophic lateral sclerosis disease progression: validation and implications for clinical trial design and analysis
Michael Benatar(University of Miami), Mary‐Louise Rogers(Flinders University), Iddo Magen(Flinders University), Caroline McHutchison(University of Edinburgh), Joanne Wuu(University of Miami), Volkan Granit(Biohaven Pharmaceuticals (United States)), Corey T. McMillan(University of Pennsylvania), Eran Hornstein(Weizmann Institute of Science), Rosa Rademakers(University of Antwerp), Jeannine M. Heckmann(University of Cape Town), Yahel Cohen(Weizmann Institute of Science), Vittoria Lombardi(Queen Mary University of London), Leonard Petrucelli(Jacksonville College), Andrea Malaspina(Queen Mary University of London), Jeffrey Statland(The University of Texas at San Antonio Health Science Center), Eric A. Macklin(Harvard University), Stephanie Shepheard(Flinders University), Danielle Renfrey(Flinders University)
Cited by 43
Related Papers
Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17
|Nature|2006|2.1k
Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions
|Nature Genetics|2010|608
Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids
|Nature Genetics|2011|578
Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration
|Human Molecular Genetics|2006|578